Publications by authors named "Estefania Prochetto"

Claim this Profile
N
Nasal vaccination against : a dual approach for prevention and treatment of chronic Chagas cardiomyopathy.
Paula Cacik, Maria Florencia Pacini, Camila Bulfoni Balbi, Brenda Dinatale, Genaro Diaz, Estefanía Prochetto

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Cellular Immune Biomarkers with Machine Learning to Identify Potential Correlates of Protection for a Vaccine.
Juan Cruz Gamba, Eliana Borgna, Estefanía Prochetto, Ana Rosa Pérez, Alexander Batista-Duharte

Vaccines (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual dimorphism-driven differences are overcome in a preclinical vaccine model against .
Camila Bulfoni Balbi, Maria Florencia Pacini, Brenda Dinatale, Cecilia Farré, Paula Cacik, Estefanía Prochetto

Front Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of myeloid-derived suppressor cell dynamics potentiates vaccine protection in multiple mouse models of infection.
Eliana Borgna, Estefanía Prochetto, Juan Cruz Gamba, Elba Mónica Vermeulen, Carolina Verónica Poncini

Front Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple protocol for measuring CD11b+ GR-1+ (Ly6C+/Ly6G+) myeloid cells from a minimum volume of mouse peripheral blood.
Eliana Borgna, Juan Cruz Gamba, Estefanía Prochetto, Iván Marcipar, Gabriel Cabrera

Methods Cell Biol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal trans-sialidase-based vaccine against Trypanosoma cruzi triggers a mixed cytokine profile in the nasopharynx-associated lymphoid tissue and confers local and systemic immunogenicity.
María F Pacini, Camila Bulfoni Balbi, Brenda Dinatale, Florencia B González, Estefania Prochetto

Acta Trop· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of myeloid-derived suppressor cells during Trypanosoma cruzi infection.
Eliana Borgna, Estefanía Prochetto, Juan Cruz Gamba, Iván Marcipar, Gabriel Cabrera

Int Rev Cell Mol Biol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid-derived suppressor cells and vaccination against pathogens.
Estefanía Prochetto, Eliana Borgna, Carlos Jiménez-Cortegana, Víctor Sánchez-Margalet, Gabriel Cabrera

Front Cell Infect Microbiol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of a combined treatment with a therapeutic vaccine and benznidazole for the Trypanosoma cruzi chronic infection.
Estefanía Prochetto, Iván Bontempi, Luz Rodeles, Gabriel Cabrera, Miguel Vicco

Acta Trop· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased epicardial adipose tissue thickness associated with increased metabolic risk and the presence of heart failure in patients with Chronic Chagas disease.
Luz María Rodeles, Maximiliano Castro, María Ayelen Gaitán Zamora, Roberto Savarino, Luz María Peverengo, Estefanía Soledad Prochetto

Trans R Soc Trop Med Hyg· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Myeloid-Derived Suppressor Cells to Enhance a Trans-Sialidase-Based Vaccine Against .
Juan Cruz Gamba, Carolina Roldán, Estefanía Prochetto, Giuliana Lupi, Iván Bontempi

Front Cell Infect Microbiol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Engineering of Co-producing Antigen and the Mucosal Adjuvant 3' 5'- cyclic di Adenosine Monophosphate (c-di-AMP) as a Design Strategy to Develop a Mucosal Vaccine Prototype.
Ingrid Quintana, Martín Espariz, Silvina R Villar, Florencia B González, Maria F Pacini, Estefanía Prochetto

Front Microbiol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trans-sialidase-based vaccine candidate protects against infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype.
Estefanía Prochetto, Carolina Roldán, Iván A Bontempi, Daiana Bertona, Luz Peverengo

Oncotarget· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trans-sialidase overcomes many antigens to be used as a vaccine candidate against Trypanosoma cruzi.
Ivan Bontempi, Pedro Fleitas, Alexia Poato, Miguel Vicco, Luz Rodeles, Estefania Prochetto

Immunotherapy· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody profiles induced by Trypanosoma cruzi in chagasic patients with previous or current exposure to mycobacteria.
Luz Peverengo, Estefanía Prochetto, Luz Rodeles, Ignacio Valenzuela, Iván Sergio Marcipar

Pathog Dis· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis